The Europe Nasal Cannula Market would witness market growth of 3.7% CAGR during the forecast period (2021-2027).
The nasal cannula is used in hospitals and other healthcare settings to supply supplementary oxygen to patients with respiratory problems. It is also useful in increasing the airflow to a patient who shows a lower oxygen saturation level. This device is made up of a lightweight tube that bifurcated into two prongs at the end. It is placed in the nostrils and from the tube mixture of air and oxygen flows. At the other end, the tube is connected to an oxygen supply like a portable oxygen generator or connected to the wall connection in a hospital through a flowmeter. The cannula is usually attached to the patient in a manner where the tube hooks either around the patient's ears or with the help of an elastic headband. The most commonly used form of the nasal cannula for adults can carry about 1–3 litres of oxygen per minute.
The nasal cannula is also recommended for elderly patients or patients who are undergoing oxygen therapy and are not able to self-respirate. These patients do not require oxygen at higher concentrations and higher flow rates. So, they don’t require wearing a non-rebreather mask. It is mainly useful for patients who are suffering from strokes where vasoconstriction could adversely impact their condition.
The demand for nasal cannula is extremely high in European countries. The healthcare sector in the UK has exhibited the importance of respiratory support methods including nasal cannula. Also, increasing awareness of the masses regarding respiratory care has also created new growth avenues for the market players. It will lead to the advancement and growth of the regional market. The demand for nasal cannula is also high due to the rise in the number of patients suffering from respiratory diseases such as chronic obstructive pulmonary disease (COPD), acute respiratory disease syndrome, and bronchiectasis. It is likely to act as a driving factor for the growth of the market. Moreover, the increasing adoption of the nasal cannula among neonates further increased the demand for nasal cannula in the healthcare sector in Europe.
The Germany market dominated the Europe Ambulatory Healthcare Services Market by Country in 2020, thereby, achieving a market value of $92.6 million by 2027. The UK market is exhibiting a CAGR of 3.5% during (2021-2027). Additionally, The France market is poised to grow at a CAGR of 5.8% during (2021-2027).
Based on Material, the market is segmented into Plastic and Silicone. Based on End Use, the market is segmented into Hospitals, Long Term Care Centers, Ambulatory Healthcare Services, and Other End Uses. Based on Type, the market is segmented into Low Flow Nasal Cannula and High Flow Nasal Cannula. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Nasal Cannula Market Size will Hit $7.9 Billion by 2027, at a CAGR of 4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Allied Healthcare Products, Inc., Besmed Health Business Corporation, ResMed, Inc., Teleflex, Inc., Medical Depot, Inc. (Drive DeVilbiss Healthcare), Fairmont Medical Products Pty. Ltd., Fisher and Paykel Healthcare Limited, Sunset Healthcare Solutions, Inc., Smiths Group PLC, and Flexicare Medical Ltd.
By Material
By End Use
By Type
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 